Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

• Aino Salmiheimo ,

  * E-mail: aino.koski@helsinki.fi

  Affiliation Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Harri Mustonen,

  Affiliation Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Ulf-Håkan Stenman,

  Affiliation Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Pauli Puolakkainen,

  Affiliation Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Esko Kemppainen,

  Affiliation Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Hanna Seppänen ,

  ¶‡ These authors share last authorship.

  Affiliation Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Caj Haglund

  ¶‡ These authors share last authorship.

  Affiliations Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Research Programs Unit, Translational Cancer Biology Program, University of Helsinki, Helsinki, Finland

  ⨯